International
Healthcare
Leadership

推进医疗政策，改善医疗卫生

Teaching, Healthcare Policy and Healthcare Management

The vision of International Healthcare Leadership (IHL) is to provide the tools needed by healthcare leaders in emerging nations to devise and test coherent healthcare policy while also providing management tools to improve healthcare infrastructure. This includes delivery, access, quality, standardization of medical training and improved public health. IHL develops partnerships with governments, non-government organizations, universities and healthcare institutions that advance the exchange of healthcare information, evidence based healthcare policy and quality of care.

Designing and Implementing Healthcare Policy

International Healthcare Leadership (IHL) designs and implements educational programs in healthcare management and health policy for highly qualified government officials and senior healthcare executives in emerging nations. The curriculum is designed with a specific focus on that emerging healthcare system and is a product of a close collaboration with university partners in the United States and in the partner nation. These leaders will take the proffered education and implement changes in the healthcare systems that they govern to improve quality and access. In developing the curriculum, IHL promotes the development of productive relationships between American faculty and their partners in emerging countries. By offering the annual course on campuses in the United States, relationships between American and the foreign healthcare leaders are potentiated.

Educate and Train Healthcare Leaders Around The World

Our goals are:

Strengthening curriculum offerings and faculty training at institutions of higher learning globally by faculty exchange and joint curriculum development.
Enhancing leadership skills and capacity of individuals and organizations to address local and global challenges by providing participants with the tools to measure the effect of policy changes and to use evidence based systems to evaluate management techniques.
Addressing the educational needs of future health care leaders by developing specific degree granting programs.
Allowing quick implementation of lessons learned by developing short, intense, and focused programs. This paradigm will increase the appeal of the IHL programs by controlling costs and allowing busy health care leaders to attend without disrupting their work or family life.
Promoting global connectivity with alumni and with faculty to potentiate continued learning and exchange of ideas and consultation by utilizing web based technology to both prepare our students for the course work and to augment the information that is communicated in class room discussions.
Advancing closer educational and cultural relations between public health students in US universities and those of other countries by ensuring that US students are also joining the IHL courses.

Our Board of Directors

David P. Roye, Jr., MD, President and Chief Executive Officer, is one of the world’s leading pediatric orthopaedic surgeons, and has spent decades providing care to children around the world. His work has taken him to Africa, Eastern Europe and to China. Dr. Roye was recently honored as Humanitarian of the Year by the American Association of Orthopaedic Surgeons. He is Chief of Pediatric Orthopaedic Surgery at the Morgan Stanley Children’s Hospital of New York-Presbyterian, and St. Giles Professor of Pediatric Orthopaedic Surgery at the Columbia University College of Physicians and Surgeons. In addition to leading the clinical team as Chief Medical Officer of the Children of China Pediatrics Foundation, and providing medical education in China, Dr. Roye has recently been invited to apply for faculty privileges at the Beijing Children’s Hospital.

Paul Anderer, Board Member, is the deBary/Class of ’41 Professor of Asian Humanities at Columbia. He holds degrees from Michigan (BA ’71), Chicago (MA ’72), and Yale (Ph.D. ’79). He joined the Columbia faculty in 1980. From 1989 until 1997, he was chair of the Department of East Asian Languages and Cultures. He has also served the University as Vice Provost for International Relations, as Associate Vice-President for Academic Planning and Global Initiatives in the Arts and Sciences, as Acting Dean of the Graduate School, and as the Director of the Keene Center of Japanese Culture. His writings include Other Worlds: Arishima Takeo and the Bounds of Modern Japanese Fiction (Columbia, 1984); and Literature of the Lost Home: Kobayashi Hideo—Literary Criticism, 1924-1939 (Stanford, 1995), along with numerous articles exploring the culture of the city (Tokyo) and Japanese modernity. His work has been awarded support from the NEH, the SSRC, and the Fulbright Commission. Professor Anderer’s teaching spans undergraduate and graduate courses on Japanese fiction, film, and cultural criticism. He regularly teaches a section of Asian Humanities in service to core education. Graduate students in modern Japanese literature whom Professor Anderer has mentored hold key positions at leading institutions throughout the U.S., Europe and East Asia. He is currently writing a book on the black and white films of Kurosawa Akira, in their relationship to the Japanese post-war and to the era of silent film-making.

Sean Cheng, Board Member, is a seasoned business manager and strategist with 10+ years of track record of delivering significant revenue growth at renowned multinationals such as Medtronic, GE (Healthcare), Ericsson, Lucent Technologies. As a senior consultant at Deloitte Consulting, Mr. Cheng currently focuses on developing business strategies for leading pharmaceutical and medical device companies. Mr. Cheng’s international experiences include increasing Medtronic’s market share in the high end Cardiac Rhythm Management device segment and device therapy market in China, and he became the youngest director at Ericsson China when he achieved record annual revenue growth of 10% for his Optical Transition Division through business model transformation. Mr. Cheng graduated from the Executive Master of Public Health program at Columbia University in 2007. He also holds a MBA from University of Michigan, and a B.S. in Electronic Engineering from Beijing University of Posts and Telecommunications. Mr. Cheng was IHL’s first fellow and has been instrumental in coordinating the curriculum development between Columbia University and the partnering universities in China.

Gordon G. Liu, Board Member, is Professor of Applied Economics, and Executive Director for Health Economics and Management Institute (HEMI) at Peking University Guanghua School of Management. Prior to Peking University, he served as tenured associate professor at University of North Carolina - Chapel Hill (2000 - 2006); and assistant professor at the University of Southern California (1994 - 2000). Professor Liu currently serves on the China State Council Expert Panel on the Urban Insurance Experiment; the China Ministry of Health Commission for Emergent Public Health. He was elected as the 2004-2005 President of the Chinese Economists Society (www.China-CES.org). He serves as Co-Editor for the journal of Value in Health, the official journal of International Society for Pharmacoeconomics and Outcomes Research (www.ISPOR.org); Editor-in-Chief for the China Journal of Pharmaceutical Economics. His primary research interests include health and development economics, health policy reform, and pharmaceutical economics. Professor Liu's current research projects are funded by the National Science Foundation, NIH, UNICEF, World Bank, and the China Medical Board, and the State government.

Conrad Lung, Board Member, is a seasoned business executive in consumer products marketing, brand management, franchising and licensing, merger and acquisition and financial management, with special emphasis on global transactions involving Asia and U.S. entities. After a brief stint in university teaching, Lung was commissioned in 1977 by a Hong Kong denim manufacturer to set up a marketing operation in New York. For 30 years, in addition to managing the merchandising, marketing and finances of fashion companies, Lung participated in the setting up of the first joint venture garment factory between a Hong Kong company and the Chinese government; setting up production facilities in other Asian, South Asian and South American countries; setting up modern logistic systems for supply chain management, and setting up retail stores in China. Through the fashion industry, Lung has built a wide network of business connections in China, Asia and the U.S. and become an advisor, partner or principal in a number of other businesses including mini-bus manufacturing in China, retail, merger and acquisition of companies in the U.S., China and other Asian countries, development of environmentally friendly and energy efficient housing, and technological transfers in the environment, energy and pharmaceutical sectors.

Gena Palumbo, Board Member, is the President and Founder of the Children of China Pediatrics Foundation and continues to provide leadership and stewardship in a volunteer capacity. A corporate lawyer who wanted to provide for the children left in the orphanages after she adopted her own daughter in China, Ms. Palumbo organizes annual medical missions that consist of up to thirty all-volunteer team members, as well as medical and surgical supplies. She provides liaison to the Chinese hospital administration and government regarding the recruitment of patients, as well as spearheads annual fundraising events. Ms. Palumbo currently holds the position of Vice President and Associate General Counsel for Goldman, Sachs & Co. in New York City.

David Wood, Board Member, is the Managing Director of Healthcare and Pharmaceutical Services for China and Hong Kong at PricewaterhouseCoopers in Beijing, China. He brings over 30-years of hospital administration and healthcare consulting experience, both domestically in the United States and internationally, to this role. He has served as President of the ChinaCare Group, a Beijing-based consulting firm, and in senior management positions with the University of California hospital system as assistant director, the University of Colorado Hospitals as chief financial officer and director of hospital operations, Cancer Research Center in California as senior vice president, the Shakut Khanum Cancer Hospital and Research Center in Pakistan as president, the United Family Hospitals in China as president and chief executive officer and the New Century International Children’s Hospital in Beijing as president and chief executive officer. In his role with the New Century International Children’s Hospital, he was the only foreigner serving as president of a Chinese hospital. His consulting activity has included assisting clients in a variety of engagements all over the world including the United States, China, Germany, England, Canada and Gambia. In his consulting practice, his clients have included Cedars-Sinai Medical Center, Siemens Project Ventures, Bumrungrad International Hospital, University of California Medical Center, University of California, Los Angeles, People’s Liberation Army Hospitals, Ministry of Health of the People’s Republic of China, Sino-German Friendship Hospital, New Century International Children’s Hospital, American Cancer Centers, Peking University International Hospital, FuWai Cardiovascular Hospital, DePfa Bank, iSoft Corporation, Vital Therapies, Inc., BUPA Health Insurance, Asia, World Link Clinics and numerous start-ups and early-stage projects He is on the China Advisory Board for Harvard Medical International and the Scientific Council for Nations Healthcareers.

Ge Zhang, PhD, MBA, Board Member, has volunteered and served as a member on both Policy Advisory Committees on Healthcare and Technology for the 2008 Obama Presidential Campaign. Dr. Zhang was educated in both China (Mandarin) and the US, receiving his MBA from Columbia Business School and his PhD in Biophysics from the University of Tennessee and Oak Ridge National Laboratory. He also completed the Harvard Business School Executive Education Program. Dr. Zhang worked on the Human Genome Project, led a group at a Biotech company through its IPO, built, from the ground up, a drug discovery informatics department at a Pharmaceutical company, as well as a biomedical informatics program at the Children’s Hospital of Philadelphia. Dr. Zhang has volunteered for the Clinton Global Initiative Conferences since its inception in 2005, and other global oriented activities including the World Business Forum, HSM Group and the Organization of Chinese Americans, Sino-American Biopharma and US-China Finance Association.

Neal Zuckerman, Board Member, is a principal in the New York office of the Boston Consulting Group, working within the firm’s media practice. Neal has worked extensively in the media, entertainment, and communications industries, with particular depth in business building, technology, advertising, and sales force effectiveness.

Since joining BCG, Neal has worked with a number of media, telecom, and technology clients and private equity investors in media companies. Neal also led the firm's 2008 Convergence Initiative, focused on emerging business models in digital businesses. Prior to joining BCG, Neal worked for Time Warner as Executive Director of its Strategic Planning group. In this role, he led business development for a variety of businesses across the company, including magazine advertising, mobile content, film production, VoIP, and innovative ad sales programs.

Neal is a former Captain in the US Army, having been stationed in several US posts and in South Korea. Neal holds a BS in European History from the United States Military Academy and an MBA from Harvard Business School. He is a former chair of WNYC Radio’s Community Board of Advisors and the president of the Putnam County Historical Society.

Contact Us